# Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis

> **NCT05752279** · PHASE3 · RECRUITING · sponsor: **The George Institute** · enrollment: 680 (estimated)

## Conditions studied

- Diabetic Ketoacidosis

## Interventions

- **DRUG:** Plasma-Lyte 148
- **DRUG:** 0.9% sodium chloride

## Key facts

- **NCT ID:** NCT05752279
- **Lead sponsor:** The George Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-14
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 680 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05752279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05752279, "Balanced Multi-Electrolyte Solution Versus Saline Trial for Diabetic KetoAcidosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05752279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*